Neonmind Biosciences Stock Net Income

NMDBFDelisted Stock  USD 0.50  0.00  0.00%   
NeonMind Biosciences fundamentals help investors to digest information that contributes to NeonMind Biosciences' financial success or failures. It also enables traders to predict the movement of NeonMind Pink Sheet. The fundamental analysis module provides a way to measure NeonMind Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NeonMind Biosciences pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

NeonMind Biosciences Company Net Income Analysis

NeonMind Biosciences' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current NeonMind Biosciences Net Income

    
  (7.21 M)  
Most of NeonMind Biosciences' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NeonMind Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, NeonMind Biosciences reported net income of (7.21 Million). This is 102.11% lower than that of the Healthcare sector and 110.29% lower than that of the Biotechnology industry. The net income for all United States stocks is 101.26% higher than that of the company.

NeonMind Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NeonMind Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of NeonMind Biosciences could also be used in its relative valuation, which is a method of valuing NeonMind Biosciences by comparing valuation metrics of similar companies.
NeonMind Biosciences is currently under evaluation in net income category among its peers.

NeonMind Fundamentals

About NeonMind Biosciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze NeonMind Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeonMind Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeonMind Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Consideration for investing in NeonMind Pink Sheet

If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites